266 related articles for article (PubMed ID: 1565479)
21. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
22. Characterization of flat revertants isolated from cells transformed by Abelson murine leukemia virus (Ab-MuLV).
Oka T; Yutsudo M; Inoue H; Higuchi F; Hakura A
J Cell Physiol; 1990 Dec; 145(3):428-33. PubMed ID: 1703165
[TBL] [Abstract][Full Text] [Related]
23. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
Qi CF; Zhou JX; Lee CH; Naghashfar Z; Xiang S; Kovalchuk AL; Fredrickson TN; Hartley JW; Roopenian DC; Davidson WF; Janz S; Morse HC
Cancer Res; 2007 Mar; 67(6):2439-47. PubMed ID: 17363561
[TBL] [Abstract][Full Text] [Related]
24. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
25. Analysis of A-MuLV transformed fibroblast lines for amplification of the c-myc, p53 and c-fos nuclear proto-oncogenes.
Colledge WH; Gebhardt A; Edge MD; Bell JC
Oncogene; 1989 Jun; 4(6):753-7. PubMed ID: 2543944
[TBL] [Abstract][Full Text] [Related]
26. Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl.
Langdon WY; Harris AW; Cory S
Oncogene Res; 1989; 4(4):253-8. PubMed ID: 2549487
[TBL] [Abstract][Full Text] [Related]
27. Infrequent p53 mutation in mouse tumors with deregulated myc.
Gutierrez MI; Bhatia K; Siwarski D; Wolff L; Magrath IT; Mushinski JF; Huppi K
Cancer Res; 1992 Feb; 52(4):1032-5. PubMed ID: 1737333
[TBL] [Abstract][Full Text] [Related]
28. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
Müller JR; Janz S; Potter M
Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
[TBL] [Abstract][Full Text] [Related]
29. Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.
Park SS; Shaffer AL; Kim JS; duBois W; Potter M; Staudt LM; Janz S
Cancer Res; 2005 Sep; 65(17):7644-52. PubMed ID: 16140930
[TBL] [Abstract][Full Text] [Related]
30. Rapid induction of IgM-secreting murine plasmacytomas by pristane and an immunoglobulin heavy-chain promoter/enhancer-driven c-myc/v-Ha-ras retrovirus.
Clynes R; Wax J; Stanton LW; Smith-Gill S; Potter M; Marcu KB
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6067-71. PubMed ID: 3137564
[TBL] [Abstract][Full Text] [Related]
31. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
32. Transformation of murine fibroblasts by a retrovirus encoding the murine c-fms proto-oncogene.
Rohrschneider LR; Rothwell VM; Nicola NA
Oncogene; 1989 Aug; 4(8):1015-22. PubMed ID: 2548144
[TBL] [Abstract][Full Text] [Related]
33. Induction of thymus-reestablishing lymphoid tumors by a murine leukemia virus carrying the avian v-myc oncogene.
Spencer RH; Brightman BK; Trepp DJ; Fan H; Chandy KG
Thymus; 1992 Aug; 20(1):47-61. PubMed ID: 1325692
[TBL] [Abstract][Full Text] [Related]
34. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
35. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
36. Transforming activity and tissue tropism of hybrid retroviral genomes containing portions of the v-abl and v-src oncogenes.
Hevezi P; Alin K; Goff SP
Oncogene; 1993 Sep; 8(9):2413-23. PubMed ID: 8361756
[TBL] [Abstract][Full Text] [Related]
37. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
[TBL] [Abstract][Full Text] [Related]
38. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
[TBL] [Abstract][Full Text] [Related]
39. The ABL-MYC retrovirus generates antigen-specific plasmacytomas by in vitro infection of activated B lymphocytes from spleen and other murine lymphoid organs.
Largaespada DA; Jackson MW; Thompson NE; Kaehler DA; Byrd LG; Mushinski JF
J Immunol Methods; 1996 Oct; 197(1-2):85-95. PubMed ID: 8890896
[TBL] [Abstract][Full Text] [Related]
40. Avian v-myc replaces chromosomal translocation in murine plasmacytomagenesis.
Potter M; Mushinski JF; Mushinski EB; Brust S; Wax JS; Wiener F; Babonits M; Rapp UR; Morse HC
Science; 1987 Feb; 235(4790):787-9. PubMed ID: 3810165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
